The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytokine Production through Suppression of Intracellular Signaling
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 2×
“PGN, poly(I:C), and CpG DNA were used as ligands for TLR2, -3, and -9, respectively (Takeuchi et al., 1999; Hemmi et al., 2000; Alexopoulou et al., 2001).”
BackgroundMethodRecognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,987
Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80119-3 · Cited by 3,362
LPS induction of gene expression in human monocytes
Guha, M., & Mackman, N. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(00)00149-2 · Cited by 2,304
MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4
Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., & Kimoto, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1777 · Cited by 2,185
Nitric oxide and superoxide in inflammation and immune regulation.
Guzik, T. J., Korbut, R., & Adamek-Guzik, T. (2003) · PubMed · Cited by 1,349
Yamamoto, M., Sato, S., Mori, K., Hoshino, K., Takeuchi, O., Takeda, K., & Akira, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6668 · Cited by 1,227
Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T., & Seya, T. (2003) · Nature Immunology · doi:10.1038/ni886 · Cited by 1,207
Self-citationLPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF
Fitzgerald, K. A., Rowe, D. C., Barnes, B. J., Caffrey, D. R., Visintin, A., Latz, E., Monks, B., Pitha, P. M., & Golenbock, D. T. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031023 · Cited by 1,193
Yamamoto, M., Sato, S., Hemmi, H., Uematsu, S., Hoshino, K., Kaisho, T., Takeuchi, O., Takeda, K., & Akira, S. (2003) · Nature Immunology · doi:10.1038/ni986 · Cited by 1,051
Hehlgans, T., & Pfeffer, K. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02143.x · Cited by 1,048
A Fluorometric Assay for the Measurement of Nitrite in Biological Samples
Misko, T. P., Schilling, R. J., Salvemini, D., Moore, W. M., & Currie, M. G. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1449 · Cited by 1,027
Toll-like Receptor 4 Polymorphisms and Atherogenesis
Kiechl, S., Lorenz, E., Reindl, M., Wiedermann, C. J., Oberhollenzer, F., Bonora, E., Willeit, J., & Schwartz, D. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012673 · Cited by 1,024
Essential role of MD-2 in LPS responsiveness and TLR4 distribution
Nagai, Y., Akashi, S., Nagafuku, M., Ogata, M., Iwakura, Y., Akira, S., Kitamura, T., Kosugi, A., Kimoto, M., & Miyake, K. (2002) · Nature Immunology · doi:10.1038/ni809 · Cited by 1,020
Nitric oxide in health and disease of the respiratory system
Ricciardolo, F. L. M., Sterk, P. J., Gaston, B., & Folkerts, G. (2004) · Physiological Reviews · doi:10.1152/physrev.00034.2003 · Cited by 903
Relevance of Mutations in the TLR4 Receptor in Patients With Gram-Negative Septic Shock
Lorenz, E., Mira, J. P., Frees, K. L., & Schwartz, D. A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.9.1028 · Cited by 729
Lipopolysaccharide Is in Close Proximity to Each of the Proteins in Its Membrane Receptor Complex
da Silva Correia, J., Soldau, K., Christen, U., Tobias, P. S., & Ulevitch, R. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009164200 · Cited by 649
CORRELATION OF PLASMA INTERLEUKIN 1 LEVELS WITH DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS
Eastgate, J., Wood, N., Di Giovine, F., Symons, J., Grinlinton, F., & Duff, G. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90185-7 · Cited by 484
Oshiumi, H., Sasai, M., Shida, K., Fujita, T., Matsumoto, M., & Seya, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305820200 · Cited by 411
Self-citationToll‐like receptors, endogenous ligands, and systemic autoimmune disease
Rifkin, I. R., Leadbetter, E. A., Busconi, L., Viglianti, G., & Marshak‐Rothstein, A. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00239.x · Cited by 389
Fischer, E., Marano, M. A., Van Zee, K. J., Rock, C. S., Hawes, A. S., Thompson, W. A., DeForge, L., Kenney, J. S., Remick, D. G., & Bloedow, D. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115748 · Cited by 333
E5531, a Pure Endotoxin Antagonist of High Potency
Christ, W. J., Asano, O., Robidoux, A. L. C., Perez, M., Wang, Y., Dubuc, G. R., Gavin, W. E., Hawkins, L. D., McGuinness, P. D., Mullarkey, M. A., et al. (1995) · Science · doi:10.1126/science.7701344 · Cited by 318
Macrophages and post-burn immune dysfunction
Schwacha, M. G. (2003) · Burns · doi:10.1016/s0305-4179(02)00187-0 · Cited by 310
Mullarkey, M., Rose, J. R., Bristol, J., Kawata, T., Kimura, A., Kobayashi, S., Przetak, M., Chow, J., Gusovsky, F., Christ, W. J., et al. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044487 · Cited by 292
The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol
Byrd-Leifer, C. A., Block, E. F., Takeda, K., Akira, S., & Ding, A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200108)31:8<2448::aid-immu2448>3.0.co;2-n · Cited by 287
Macrophages, inflammation, and atherosclerosis
Linton, M. F., & Fazio, S. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802498 · Cited by 277
Mammalian Toll-like receptors: to immunity and beyond
Hopkins, P. A., & Sriskandan, S. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02801.x · Cited by 220
Fort, M. M., Mozaffarian, A., Stöver, A. G., Correia, J. D. S., Johnson, D. A., Crane, R. T., Ulevitch, R. J., Persing, D. H., Bielefeldt-Ohmann, H., Probst, P., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6416 · Cited by 216
Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases
O'Neill, L. A. J. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00080-8 · Cited by 167
Adaptor usage and Toll‐like receptor signaling specificity
Dunne, A., & O'Neill, L. A. J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.024 · Cited by 156
Nitric oxide in health and disease
(1998) · Nature Medicine · doi:10.1038/nm0198-101b · Cited by 151
Sousa, A. R., Lane, S. J., Nakhosteen, J. A., Lee, T. H., & Poston, R. N. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.4.8887608 · Cited by 127
Alterations of the mucosal immune system in inflammatory bowel disease
MacDermoit, R. P. (1996) · Journal of Gastroenterology · doi:10.1007/bf02358624 · Cited by 121
Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis, and myelodysplastic syndromes
Raza, A. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20000801)50:3<229::aid-jemt6>3.0.co;2-h · Cited by 101
Antagonism of in vivo and ex vivo response to endotoxin by E5564, a synthetic lipid A analogue
Rossignol, D. P., & Lynn, M. (2002) · Journal of Endotoxin Research · doi:10.1179/096805102125001127 · Cited by 88
Ellingsen, E. B., Morath, S., Flo, T. H., Schromm, A. B., Härtung, T., Thiemermann, C., Espevik, T., Golenbock, D. T., Foster, D., Solberg, R., et al. (2002) · PubMed · Cited by 87
Triantafilou, M., Triantafilou, K., & Fernández, N. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01222.x · Cited by 48
Nitric oxide. A key mediator in sepsis and endotoxaemia?
Parratt, J. R. (1997) · PubMed · Cited by 44
Muzio, M., & Mantovani, A. (2001) · Allergy · doi:10.1034/j.1398-9995.2001.056002103.x · Cited by 33
Cited by
Signaling to NF-κB by Toll-like receptors
Kawai, T., & Akira, S. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.09.002 · Cited by 2,388
Targeting Toll-like receptors: emerging therapeutics?
Hennessy, E. J., Parker, A. E., & O'Neill, L. A. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3203 · Cited by 886
The Pathogenesis of Sepsis and Potential Therapeutic Targets
Huang, M., Cai, S., & Su, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215376 · Cited by 776
Inflammation in intracerebral hemorrhage: From mechanisms to clinical translation
Zhou, Y., Wang, Y., Wang, J., Anne Stetler, R., & Yang, Q.-W. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.003 · Cited by 628
Toll-Like Receptor-4 Promotes the Development of Colitis-Associated Colorectal Tumors
Fukata, M., Chen, A., Vamadevan, A. S., Cohen, J., Breglio, K., Krishnareddy, S., Hsu, D., Xu, R., Harpaz, N., Dannenberg, A. J., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.008 · Cited by 621
Metadata
- Authors
- Ii, M., Matsunaga, N., Hazeki, K., Nakamura, K., Takashima, K., Seya, T., Hazeki, O., Kitazaki, T., & Iizawa, Y.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2006-04
- Volume
- 69
- Issue
- 4
- Pages
- 1288-1295
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2162826697
- Cited by
- 377
- References
- 40
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.